CN102526470A - 一种治疗原发性高血压的药物组合物 - Google Patents
一种治疗原发性高血压的药物组合物 Download PDFInfo
- Publication number
- CN102526470A CN102526470A CN201210034715XA CN201210034715A CN102526470A CN 102526470 A CN102526470 A CN 102526470A CN 201210034715X A CN201210034715X A CN 201210034715XA CN 201210034715 A CN201210034715 A CN 201210034715A CN 102526470 A CN102526470 A CN 102526470A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- root
- medicinal composition
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000007530 Essential hypertension Diseases 0.000 title claims abstract description 15
- 239000000203 mixture Substances 0.000 title abstract description 9
- 239000003814 drug Substances 0.000 claims description 36
- 239000007788 liquid Substances 0.000 claims description 27
- 239000008194 pharmaceutical composition Substances 0.000 claims description 11
- 241000628997 Flos Species 0.000 claims description 9
- 241000237636 Pheretima Species 0.000 claims description 8
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 4
- 241001530126 Scrophularia Species 0.000 claims description 2
- 241000207929 Scutellaria Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 9
- 230000001077 hypotensive effect Effects 0.000 abstract description 6
- 230000002045 lasting effect Effects 0.000 abstract description 5
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract description 2
- 241000729173 Cirsium japonicum Species 0.000 abstract description 2
- 240000000249 Morus alba Species 0.000 abstract description 2
- 244000170916 Paeonia officinalis Species 0.000 abstract description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract description 2
- 240000007164 Salvia officinalis Species 0.000 abstract description 2
- 241001254604 Angelica pubescens Species 0.000 abstract 1
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 241000243684 Lumbricus Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 240000002948 Ophiopogon intermedius Species 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229940126678 chinese medicines Drugs 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 229940079593 drug Drugs 0.000 description 16
- 239000012567 medical material Substances 0.000 description 16
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 206010020772 Hypertension Diseases 0.000 description 8
- 238000004321 preservation Methods 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010043458 Thirst Diseases 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 230000001631 hypertensive effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 2
- 244000192528 Chrysanthemum parthenium Species 0.000 description 2
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010020741 Hyperpyrexia Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241000207844 Scrophulariaceae Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000002220 antihypertensive agent Substances 0.000 description 2
- 229940127088 antihypertensive drug Drugs 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 235000008384 feverfew Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000035488 systolic blood pressure Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 239000004072 C09CA03 - Valsartan Substances 0.000 description 1
- 241000131317 Capitulum Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 108010061435 Enalapril Proteins 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 229930195210 Ophiopogon Natural products 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000405911 Rehmannia glutinosa Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 241001121987 Scrophularia ningpoensis Species 0.000 description 1
- 240000004534 Scutellaria baicalensis Species 0.000 description 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- GBXSMTUPTTWBMN-XIRDDKMYSA-N enalapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 GBXSMTUPTTWBMN-XIRDDKMYSA-N 0.000 description 1
- 229960000873 enalapril Drugs 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- SJSNUMAYCRRIOM-QFIPXVFZSA-N valsartan Chemical compound C1=CC(CN(C(=O)CCCC)[C@@H](C(C)C)C(O)=O)=CC=C1C1=CC=CC=C1C1=NN=N[N]1 SJSNUMAYCRRIOM-QFIPXVFZSA-N 0.000 description 1
- 229960004699 valsartan Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 灌胃物及剂量 |
模型对照组 | 等体积0.9%生理盐水 |
阳性对照组 | 10mg/(kg·d)缬沙坦 |
试验组 | 10ml/kg/d本发明实施例1制备的中药口服液 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210034715XA CN102526470B (zh) | 2012-02-16 | 2012-02-16 | 一种治疗原发性高血压的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210034715XA CN102526470B (zh) | 2012-02-16 | 2012-02-16 | 一种治疗原发性高血压的药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102526470A true CN102526470A (zh) | 2012-07-04 |
CN102526470B CN102526470B (zh) | 2013-05-29 |
Family
ID=46335290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210034715XA Active CN102526470B (zh) | 2012-02-16 | 2012-02-16 | 一种治疗原发性高血压的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102526470B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105726703A (zh) * | 2016-04-28 | 2016-07-06 | 蓝国希 | 一种治疗原发性高血压的中药 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1868532A (zh) * | 2005-05-23 | 2006-11-29 | 邓大勇 | 一种治疗高血压病的药物 |
CN102198228A (zh) * | 2011-05-10 | 2011-09-28 | 李平 | 治疗高血压的中药制剂 |
-
2012
- 2012-02-16 CN CN201210034715XA patent/CN102526470B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1868532A (zh) * | 2005-05-23 | 2006-11-29 | 邓大勇 | 一种治疗高血压病的药物 |
CN102198228A (zh) * | 2011-05-10 | 2011-09-28 | 李平 | 治疗高血压的中药制剂 |
Non-Patent Citations (1)
Title |
---|
陈其剑: "中药临床辨治高血压病", 《四川中医》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105726703A (zh) * | 2016-04-28 | 2016-07-06 | 蓝国希 | 一种治疗原发性高血压的中药 |
Also Published As
Publication number | Publication date |
---|---|
CN102526470B (zh) | 2013-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103272169B (zh) | 一种红景天复方组合物在治疗糜烂性胃炎中的用途 | |
CN102698137B (zh) | 一种具有降低血压作用的组合物及其制备方法 | |
CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN104069339B (zh) | 一种治疗重症肌无力的中药组合物及其制备方法 | |
CN102106941B (zh) | 治疗痔疮的中药制剂及其制备方法 | |
CN104689226A (zh) | 一种治疗小儿类风湿性关节炎的中药组合物及其制备方法 | |
CN102552696A (zh) | 一种复方消渴口服制剂及其制备方法 | |
CN104984316A (zh) | 用于治疗女性宫寒的药物 | |
CN103301267A (zh) | 一种治疗高血压和/或动脉粥样硬化的中药组合物及应用 | |
CN104857366A (zh) | 一种神经外科术前干预药物组合物及其应用 | |
CN106177477A (zh) | 一种用于降血糖、降血脂和降血压的保健组合物 | |
CN104306659A (zh) | 一种治疗2型糖尿病的中药组合物 | |
CN104107348A (zh) | 一种降血糖用中草药及其服用方法 | |
CN103705860B (zh) | 一种治疗婴幼儿黄疸的中药组合物及其制备方法 | |
CN103202956A (zh) | 一种降血压养生保健药酒 | |
CN102526470B (zh) | 一种治疗原发性高血压的药物组合物 | |
CN101757408A (zh) | 一种***的药物及其制备方法 | |
CN1943755B (zh) | 一种治疗高血压的中药组合物及其制备方法 | |
CN105727089A (zh) | 含艾叶的药物组合物用于制备治疗肠易激综合症药物中的用途 | |
CN101085165A (zh) | 一种内服治疗病毒性心肌炎的中药组合物 | |
CN102406913A (zh) | 一种治疗郁证的中药组合物 | |
CN102526449B (zh) | 一种治疗心肌缺血型冠心病的药物组合物 | |
CN104127707A (zh) | 一种治疗脱发病中药 | |
CN103893598A (zh) | 一种治疗失眠的中药 | |
CN103330896A (zh) | 一种治疗产后非特异性***炎的散剂制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: CUI HEFANG Free format text: FORMER OWNER: XU CONGYU Effective date: 20130320 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Yao Difei Inventor before: Shao Mingfeng |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: SHAO MINGFENG TO: YAO DIFEI Free format text: CORRECT: ADDRESS; FROM: 276017 LINYI, SHANDONG PROVINCE TO: 266200 QINGDAO, SHANDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20130320 Address after: 266200 Jimo, Shandong, the Yellow River Road No. two, No. 182, No. Applicant after: Cui Hefang Address before: 276017 A302 building, Linyi hi tech Industrial Development Zone, Shandong, China Applicant before: Xu Congyu |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: QIDONG SANJIANG CONSTRUCTION MACHINERY CO., LTD. Free format text: FORMER OWNER: CUI HEFANG Effective date: 20140801 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 266200 QINGDAO, SHANDONG PROVINCE TO: 226200 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140801 Address after: 226200 Nanhai Road, Binhai Industrial Park, Nantong, Jiangsu, Qidong Patentee after: Qidong Sanjiang Construction Machinery Co., Ltd. Address before: 266200 Jimo, Shandong, the Yellow River Road No. two, No. 182, No. Patentee before: Cui Hefang |